Thu, June 22, 2023

Matthew Caufield Reiterated (ALDX) at Strong Buy and Held Target at $15 on, Jun 22nd, 2023

Matthew Caufield of HC Wainwright & Co., Reiterated "Aldeyra Therapeutics, Inc." (ALDX) at Strong Buy and Held Target at $15 on, Jun 22nd, 2023.

Matthew has made no other calls on ALDX in the last 4 months.



There is 1 other peer that has a rating on ALDX. Out of the 1 peers that are also analyzing ALDX, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $25 on, Thursday, June 1st, 2023